-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
March 26, 2021 // - Recently, in a research report titled "The landscape of the heritable cancer genome" published in the international journal Cancer Research , scientists from the University of Edinburgh and other institutions said through research that, Revealing new cancer mutations may be expected to help enhance the diagnosis of cancer and the development of personalized anti-cancer therapies.
Cancer Research scientists from the University of Edinburgh and other institutions have shown through research that revealing new cancer mutations may be expected to help enhance the diagnosis of cancer and the development of individualized anti-cancer therapies.
jpg">
In this study, the genetic mutations discovered by the researchers are inherited from parents to children.
Compared with mutations that occur accidentally with age or other risk factors (such as smoking or sun exposure), cancers caused by genetic errors were previously considered very rare.
Previous studies have found that for individual populations, such genetic mutations may not significantly increase the risk of cancer, and they are often excluded from further research.
Research results show that these collective mutations increase the possibility of cancer, including late-onset cancers, such as prostate cancer and bladder cancer.
These collective mutations increase the possibility of cancer, including late-onset cancers, such as prostate cancer and bladder cancer.
jpg">
Image source: CC0 Public Domain
In general, in this study, the researchers identified 1146 genes, which are called cancer heritability genes (CHGs, cancer heritability genes), which often promote an individual's chance of developing cancer in their lifetime.
Researchers have identified 1146 genes, which are called cancer heritability genes (CHGs, cancer heritability genes), which often promote an individual's chance of developing cancer in their lifetime.
Reference materials:
Reference materials:[1] Viola Fanfani, Luca Citi, Adrian L Harris, et al.
[1] Viola Fanfani, Luca Citi, Adrian L Harris, et al.
[2] com/news/2021-03-cancer-mutations-insight-boost-personalize.
by University of Edinburgh
